Metabolic & GLP-1 Analogues
GLP-1 Receptor Agonist Analogue
Scientific Profile
Semaglutide is a GLP-1 analog with amino acid modifications including Aib substitution at position 8 and C18 fatty acid diacid attachment via glutamate linker. In vitro studies demonstrate high affinity binding to GLP-1 receptors with resistance to DPP-4 degradation.
Animal models show prolonged activation of cAMP signaling pathways due to albumin binding properties. The fatty acid modification significantly extends its half-life while maintaining receptor activation properties.
This compendium provides objective scientific information on research peptides based solely on published literature. All descriptions are limited to biochemical properties and mechanisms observed in in-vitro or animal studies, with no implications regarding human efficacy or therapeutic applications.